bismuth subsalicylate 35 MG/ML Oral Suspension [Pepto-bismol]
RxNorm concept 211915, branded drug (sbd). Prescribable name: Pepto-Bismol Max Strength 1050 MG in 30 mL Oral Suspension.
- RxCUI
- 211915
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/211915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Pepto-bismol 35 MG/ML Oral Suspension; Pepto-bismol 525 MG per 15 ML Oral Suspension; Pepto-bismol Max Strength 1050 MG per 30 ML Oral Suspension
Related concepts
- bismuth subsalicylate 35 MG/ML (SCDC, consists of)
- bismuth subsalicylate 35 MG/ML [Pepto-bismol] (SBDC, consists of)
- Oral Suspension (DF, has dose form)
- Pepto-bismol (BN, has ingredient)
- bismuth subsalicylate 35 MG/ML Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 00149085600
- 00149085601
- 00149085602
- 01490003928
- 01490003929
- 01490003930
- 37000001901
- 37000001902
- 37000001903
- 37000044004
- 37000044008
- 37000044012
- 37000044036
- 37000044112
- 37000044116
- 37000044132
- 37000065304
- 37000065308
- 37000065312
- 69423096612
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 211915 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/211915 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 211915. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.